REGN logo

REGN Total expenses

Annual total expenses:

$10.11B+$1.23B(+13.80%)
December 31, 2024

Summary

  • As of today (August 18, 2025), REGN annual total expenses is $10.11 billion, with the most recent change of +$1.23 billion (+13.80%) on December 31, 2024.
  • During the last 3 years, REGN annual total expenses has risen by +$3.03 billion (+42.86%).
  • REGN annual total expenses is now at all-time high.

Performance

1-year change

+13.8%

3-year change

+42.86%

5-year change

+132.54%

15-year change

+166.58%

REGN Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.99%
REGN annual total expenses is higher than 95.99% of companies in Healthcare sector

Range

All-time high

$10.11B
REGN annual total expenses is currently at an all-time high

3-year low

$7.08B
REGN annual total expenses is currently +42.86% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
REGN previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
REGN next annual earnings announcement has not yet been scheduled

OtherREGNincome statement metrics

annual interest expense

$0.00
REGN annual interest expense is $0.00

annual income tax

$367.30M
REGN annual income tax is $367.30 million

annual operating expenses

$8.14B
REGN annual total operating expenses is $8.14 billion

annual cost of goods sold

$2.45B
REGN annual cost of goods sold is $2.45 billion

Quarterly total expenses:

$2.28B+$64.00M(+2.88%)
June 30, 2025

Summary

  • As of today (August 18, 2025), REGN quarterly total expenses is $2.28 billion, with the most recent change of +$64.00 million (+2.88%) on June 30, 2025.
  • Over the past year, REGN quarterly total expenses has increased by +$169.20 million (+8.00%).
  • REGN quarterly total expenses is now -20.46% below its all-time high of $2.87 billion, reached on December 31, 2024.

Performance

3-month change

+2.88%

1-year change

+8%

3-year change

+13.91%

5-year change

+116.55%

REGN Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

95.69%
REGN quarterly total expenses is higher than 95.69% of companies in Healthcare sector

Range

All-time high

$2.87B
REGN quarterly total expenses is currently -20.46% below its historical high of $2.87 billion

3-year low

$1.62B
REGN quarterly total expenses is currently +40.94% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
REGN previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
REGN next earnings announcement is scheduled for Oct 30, 2025

OtherREGNincome statement metrics

quarterly interest expense

$3.60M
REGN quarterly interest expense is $3.60 million

quarterly income tax

$127.10M
REGN quarterly income tax is $127.10 million

quarterly operating expenses

$1.92B
REGN quarterly total operating expenses is $1.92 billion

quarterly cost of goods sold

$665.30M
REGN quarterly cost of goods sold is $665.30 million

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual total expenses

$10.11B
REGN annual total expenses is $10.11 billion

annual cost of goods sold

$2.45B
REGN annual cost of goods sold is $2.45 billion

annual operating expenses

$8.14B
REGN annual total operating expenses is $8.14 billion

REGN Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.8%+8.0%
3 y3 years+42.9%+13.9%
5 y5 years+132.5%+116.5%

REGN Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+42.9%-20.5%+40.9%
5 y5-yearat high+132.5%-20.5%+116.5%
alltimeall timeat high>+9999.0%-20.5%+4192.8%

REGN Total expenses History

DateAnnualQuarterly
Jun 2025
-
$2.28B(+2.9%)
Mar 2025
-
$2.22B(-22.7%)
Dec 2024
$10.11B(+13.8%)
$2.87B(+20.6%)
Sep 2024
-
$2.38B(+12.5%)
Jun 2024
-
$2.11B(-12.7%)
Mar 2024
-
$2.42B(+6.5%)
Dec 2023
$8.88B(+23.8%)
$2.27B(-3.4%)
Sep 2023
-
$2.35B(+7.5%)
Jun 2023
-
$2.19B(-6.6%)
Mar 2023
-
$2.34B(+5.7%)
Dec 2022
$7.18B(+1.4%)
$2.22B(+36.8%)
Sep 2022
-
$1.62B(-19.2%)
Jun 2022
-
$2.01B(+0.7%)
Mar 2022
-
$1.99B(-26.9%)
Dec 2021
$7.08B(+43.8%)
$2.72B(+49.5%)
Sep 2021
-
$1.82B(-10.7%)
Jun 2021
-
$2.04B(+44.3%)
Mar 2021
-
$1.41B(+11.0%)
Dec 2020
$4.92B(+13.2%)
$1.27B(-12.3%)
Sep 2020
-
$1.45B(+37.7%)
Jun 2020
-
$1.05B(-12.4%)
Mar 2020
-
$1.20B(+12.3%)
Dec 2019
$4.35B(+66.5%)
$1.07B(-0.2%)
Sep 2019
-
$1.07B(-22.4%)
Jun 2019
-
$1.38B(+51.9%)
Mar 2019
-
$911.50M(-17.7%)
Dec 2018
$2.61B(-31.2%)
$1.11B(+3.6%)
Sep 2018
-
$1.07B(+1.2%)
Jun 2018
-
$1.06B(+2.2%)
Mar 2018
-
$1.03B(-26.6%)
Dec 2017
$3.79B(+7.4%)
$1.41B(+26.7%)
Sep 2017
-
$1.11B(+2.8%)
Jun 2017
-
$1.08B(+1.2%)
Mar 2017
-
$1.07B(+9.9%)
Dec 2016
$3.53B(+23.8%)
$973.71M(+1.9%)
Sep 2016
-
$955.32M(-6.0%)
Jun 2016
-
$1.02B(-0.3%)
Mar 2016
-
$1.02B(+8.1%)
Dec 2015
$2.85B(+42.9%)
$943.08M(+1.7%)
Sep 2015
-
$927.02M(+15.3%)
Jun 2015
-
$803.97M(+1.3%)
Mar 2015
-
$793.59M(+14.7%)
Dec 2014
$2.00B(+46.6%)
$692.15M(+7.1%)
Sep 2014
-
$646.07M(+12.8%)
Jun 2014
-
$572.97M(+2.3%)
Mar 2014
-
$560.30M(+9.1%)
Dec 2013
$1.36B(+47.9%)
$513.61M(+12.7%)
Sep 2013
-
$455.72M(+23.1%)
Jun 2013
-
$370.27M(+8.6%)
Mar 2013
-
$340.79M(-710.7%)
Dec 2012
$920.76M(+41.4%)
-$55.80M(-123.6%)
Sep 2012
-
$236.22M(+3.8%)
Jun 2012
-
$227.66M(+3.4%)
Mar 2012
-
$220.14M(+24.8%)
Dec 2011
$650.98M(+17.0%)
$176.42M(+6.8%)
Sep 2011
-
$165.20M(-3.0%)
Jun 2011
-
$170.31M(+9.4%)
Mar 2011
-
$155.65M(+5.0%)
Dec 2010
$556.55M(+22.8%)
$148.27M(+6.0%)
Sep 2010
-
$139.85M(-1.1%)
Jun 2010
-
$141.36M(+5.4%)
Mar 2010
-
$134.06M(+0.6%)
Dec 2009
$453.37M(+39.6%)
$133.29M(+12.5%)
Sep 2009
-
$118.47M(+12.9%)
Jun 2009
-
$104.97M(+16.2%)
Mar 2009
-
$90.37M(+3.5%)
Dec 2008
$324.71M
$87.36M(+0.8%)
Sep 2008
-
$86.70M(+9.6%)
Jun 2008
-
$79.11M(+16.3%)
DateAnnualQuarterly
Mar 2008
-
$68.00M(-12.6%)
Dec 2007
$239.48M(+40.0%)
$77.80M(+33.8%)
Sep 2007
-
$58.15M(+18.7%)
Jun 2007
-
$48.97M(+7.1%)
Mar 2007
-
$45.70M(+10.6%)
Dec 2006
$171.10M(-393.8%)
$41.32M(-4.0%)
Sep 2006
-
$43.03M(+0.5%)
Jun 2006
-
$42.83M(+8.7%)
Mar 2006
-
$39.41M(-16.3%)
Dec 2005
-$58.23M(-134.6%)
$47.10M(-7.4%)
Sep 2005
-
$50.85M(+17.3%)
Jun 2005
-
$43.37M(+113.3%)
Mar 2005
-
$20.33M(-54.1%)
Dec 2004
$168.37M(+6.9%)
$44.30M(-6.9%)
Sep 2004
-
$47.59M(+10.8%)
Jun 2004
-
$42.97M(-1790.3%)
Mar 2004
-
-$2.54M(-106.3%)
Dec 2003
$157.49M(+9.4%)
$40.65M(-9.2%)
Sep 2003
-
$44.79M(+14.1%)
Jun 2003
-
$39.27M(-2.4%)
Mar 2003
-
$40.25M(-0.9%)
Dec 2002
$143.94M(+33.7%)
$40.60M(+3.1%)
Sep 2002
-
$39.38M(+9.4%)
Jun 2002
-
$35.99M(+18.4%)
Mar 2002
-
$30.39M(-7.3%)
Dec 2001
$107.66M(+27.3%)
$32.78M(+29.0%)
Sep 2001
-
$25.41M(+23.3%)
Jun 2001
-
$20.61M(+6.5%)
Mar 2001
-
$19.35M(-30.6%)
Dec 2000
$84.55M(+45.0%)
$27.87M(+90.7%)
Sep 2000
-
$14.62M(-16.0%)
Jun 2000
-
$17.40M(-2.3%)
Mar 2000
-
$17.82M(+34.2%)
Dec 1999
$58.30M(+14.8%)
$13.27M(-18.2%)
Sep 1999
-
$16.23M(+8.1%)
Jun 1999
-
$15.00M(+4.3%)
Mar 1999
-
$14.39M(+9.7%)
Dec 1998
$50.80M(+25.1%)
$13.12M(+7.5%)
Sep 1998
-
$12.20M(-6.5%)
Jun 1998
-
$13.05M(+8.1%)
Mar 1998
-
$12.08M(+18.4%)
Dec 1997
$40.60M(-1.9%)
$10.20M(+2.0%)
Sep 1997
-
$10.00M(-2.9%)
Jun 1997
-
$10.30M(0.0%)
Mar 1997
-
$10.30M(-6.4%)
Dec 1996
$41.40M(+18.3%)
$11.00M(+3.8%)
Sep 1996
-
$10.60M(+7.1%)
Jun 1996
-
$9.90M(0.0%)
Mar 1996
-
$9.90M(+16.5%)
Dec 1995
$35.00M(-33.2%)
$8.50M(-1.2%)
Sep 1995
-
$8.60M(-3.4%)
Jun 1995
-
$8.90M(-1.1%)
Mar 1995
-
$9.00M(-29.7%)
Dec 1994
$52.40M(+6.1%)
$12.80M(+1.6%)
Sep 1994
-
$12.60M(-7.4%)
Jun 1994
-
$13.60M(+1.5%)
Mar 1994
-
$13.40M(-5.0%)
Dec 1993
$49.40M(+65.8%)
$14.10M(+9.3%)
Sep 1993
-
$12.90M(+16.2%)
Jun 1993
-
$11.10M(-1.8%)
Mar 1993
-
$11.30M(+34.5%)
Dec 1992
$29.80M(+76.3%)
$8.40M(+5.0%)
Sep 1992
-
$8.00M(+19.4%)
Jun 1992
-
$6.70M(0.0%)
Mar 1992
-
$6.70M(+17.5%)
Dec 1991
$16.90M(+103.6%)
$5.70M(+29.5%)
Sep 1991
-
$4.40M(+18.9%)
Jun 1991
-
$3.70M
Dec 1990
$8.30M
-

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual total expenses?
  • What is the all time high annual total expenses for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual total expenses year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly total expenses?
  • What is the all time high quarterly total expenses for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly total expenses year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual total expenses?

The current annual total expenses of REGN is $10.11B

What is the all time high annual total expenses for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual total expenses is $10.11B

What is Regeneron Pharmaceuticals, Inc. annual total expenses year-on-year change?

Over the past year, REGN annual total expenses has changed by +$1.23B (+13.80%)

What is Regeneron Pharmaceuticals, Inc. quarterly total expenses?

The current quarterly total expenses of REGN is $2.28B

What is the all time high quarterly total expenses for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly total expenses is $2.87B

What is Regeneron Pharmaceuticals, Inc. quarterly total expenses year-on-year change?

Over the past year, REGN quarterly total expenses has changed by +$169.20M (+8.00%)
On this page